Aurora Cannabis (NASDAQ:ACB) Announces Earnings Results

Aurora Cannabis (NASDAQ:ACB) released its earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a negative return on equity of 2.19% and a negative net margin of 17.47%.

Aurora Cannabis Price Performance

NASDAQ ACB opened at $5.37 on Thursday. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $294.60 million, a PE ratio of -7.07 and a beta of 1.85. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The company has a 50 day moving average price of $4.21 and a two-hundred day moving average price of $5.16.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ACB shares. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. TD Cowen started coverage on Aurora Cannabis in a research report on Wednesday, December 11th. They set a “buy” rating for the company.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.